CIK 0001681682 · Non-accelerated filer<br>Smaller reporting company
ENDRA Life Sciences Inc.
Sign in to watch- Ticker
- NDRA
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260579295
- Phone
- 734-335-0468
- Business address
- 3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
- Former names
- Endra Inc.
- 424B7 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at an average $1.56 ($15,550)
- 8-K Event Delisting notice
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Regulation FD disclosure
- 4 Open-market buy Director bought 500 shares at $1.14 ($570)
- 4 Open-market buy Director bought 9,500 shares at an average $1.11 ($10,582)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Shareholder vote results
- 4 Open-market buy Chief Technology Officer bought 30,000 shares at $1.13 ($33,900)
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
Page 20 of 28 · 547 filings